Prognostic impact of systematic lymphadenectomy during interval debulking surgery after neoadjuvant chemotherapy in stage III ovarian cancer: A 38-institution retrospective cohort study using inverse probability of treatment weighting.
SyLND was associated with better PFS and OS in patients with stage III ovarian cancer undergoing IDS, and pre-NACT nodal assessment may help determine the indications for SyLND during IDS.